Medicine
Verapamil 5 mg/2 mL injection
Verapamil 5 mg/2 mL injection is a generic prescription medicine for intravenous use, made by 20 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 59° to 86°F (15° to 30°C) HOW SUPPLIED
Key facts
- Active ingredient (INN)
- Verapamil
- Brand
- Sold under the generic name
- Strength
- 5 mg/2 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 25 cartons of 2 mL, 5 vials of 2 mL, 25 vials of 2 mL and 44 more
- Manufacturers
- EugiaIndiaMicro LabsIndiaZydus LifesciencesIndiaAvet PharmaceuticalsIndiaLifestar PharmaIndiaCaplin SterilesIndiaGland PharmaIndiaMedical Purchasing SolutionsExela Pharma SciencesHospira20 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 59° to 86°F (15° to 30°C) HOW SUPPLIED
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C08DA01 Verapamil
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 February 2005
- Identifiers
- RxCUI 1665057, 1665061, 898316DailyMed set ID 9a4f12ec-fe1c-a1b9-e053-2a95a90ac8e4, 4dcc46d8-76b0-fbd4-e063-6294a90ad9e6, 424f538f-8785-8279-e063-6394a90aeb4c +30NDC 51662-1442, 51662-1686, 71872-7356 +31Application NDA018925, ANDA211015, ANDA214653 +11
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 20 labelers. The register lists 47 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 carton in 1 carton / 5 vial in 1 carton / 2 mL in 1 vial | 70710-1643-7 | Zydus LifesciencesIndia | 22 October 2020 |
| 25 carton in 1 carton / 5 vial in 1 carton / 2 mL in 1 vial | 70710-1937-7 | Zydus LifesciencesIndia | 17 October 2023 |
| 25 carton in 1 carton / 5 vial in 1 carton / 2 mL in 1 vial | 70771-1601-7 | Zydus LifesciencesIndia | 22 October 2020 |
| 5 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 23155-911-41 | Avet PharmaceuticalsIndia | 15 January 2025 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 23155-911-42 | Avet PharmaceuticalsIndia | 15 January 2025 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 65145-113-25 | Caplin SterilesIndia | 16 January 2025 |
| 1 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 55150-342-01 | EugiaIndia | 6 July 2020 |
| 5 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 55150-342-05 | EugiaIndia | 6 July 2020 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 55150-342-25 | EugiaIndia | 6 July 2020 |
| 25 vial in 1 carton / 2 mL in 1 vial | 68083-447-25 | Gland PharmaIndia | 15 October 2020 |
| 5 vial in 1 carton / 2 mL in 1 vial | 70756-605-05 | Lifestar PharmaIndia | 16 June 2022 |
| 25 vial in 1 carton / 2 mL in 1 vial | 70756-605-25 | Lifestar PharmaIndia | 16 June 2022 |
| 1 vial in 1 carton / 2 mL in 1 vial | 42571-313-75 | Micro LabsIndia | 4 March 2019 |
| 25 vial in 1 carton / 2 mL in 1 vial | 42571-313-87 | Micro LabsIndia | 24 April 2019 |
| 5 vial in 1 carton / 2 mL in 1 vial | 42571-313-97 | Micro LabsIndia | 24 April 2019 |
| 25 vial in 1 carton / 2 mL in 1 vial | 0409-1144-05 | Hospira | 2 February 2011 |
| 25 vial, single-dose in 1 tray / 2 mL in 1 vial, single-dose | 0409-1144-10 | Hospira | 20 June 2018 |
| 5 ampule in 1 container / 2 mL in 1 ampule | 0409-4011-01 | Hospira | 28 February 2005 |
| 5 vial in 1 carton / 2 mL in 1 vial | 51754-0203-2 | Exela Pharma Sciences | 22 April 2016 |
| 25 vial in 1 carton / 2 mL in 1 vial | 51754-0203-4 | Exela Pharma Sciences | 9 December 2016 |
| 5 vial in 1 carton / 2 mL in 1 vial | 51754-0204-2 | Exela Pharma Sciences | 1 February 2017 |
| 25 vial in 1 carton / 2 mL in 1 vial | 51754-0204-4 | Exela Pharma Sciences | 1 February 2017 |
| 5 vial in 1 carton / 2 mL in 1 vial | 70069-271-05 | Somerset Therapeutics | 18 June 2018 |
| 25 vial in 1 carton / 2 mL in 1 vial | 70069-271-25 | Somerset Therapeutics | 18 June 2018 |
| 5 ampule in 1 tray / 2 mL in 1 ampule | 70069-273-05 | Somerset Therapeutics | 18 June 2018 |
| 25 vial in 1 carton / 2 mL in 1 vial | 70121-1585-5 | Amneal Pharmaceuticals | 17 July 2018 |
| 5 vial in 1 carton / 2 mL in 1 vial | 72485-108-05 | Armas Pharmaceuticals | 1 January 2020 |
| 25 vial in 1 carton / 2 mL in 1 vial | 72485-108-25 | Armas Pharmaceuticals | 1 January 2020 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 43066-031-25 | Baxter Healthcare | 25 March 2020 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 65219-384-02 | Fresenius Kabi | 25 November 2024 |
| 25 vial in 1 carton / 2 mL in 1 vial | 25021-312-02 | Sagent Pharmaceuticals | 15 March 2021 |
| 1 vial in 1 bag / 2 mL in 1 vial | 71872-7048-1 | Medical Purchasing Solutions | 28 February 2018 |
| 1 vial in 1 bag / 2 mL in 1 vial | 71872-7183-1 | Medical Purchasing Solutions | 18 November 2019 |
| 1 vial in 1 bag / 2 mL in 1 vial | 71872-7203-1 | Medical Purchasing Solutions | 12 February 2020 |
| 1 vial in 1 bag / 2 mL in 1 vial | 71872-7210-1 | Medical Purchasing Solutions | 30 March 2020 |
| 1 vial in 1 bag / 2 mL in 1 vial | 71872-7243-1 | Medical Purchasing Solutions | 12 March 2021 |
| 1 vial in 1 bag / 2 mL in 1 vial | 71872-7291-1 | Medical Purchasing Solutions | 3 June 2022 |
| 1 vial in 1 bag / 2 mL in 1 vial | 71872-7356-1 | Medical Purchasing Solutions | 10 August 2025 |
| 2 mL in 1 vial, single-dose | 51662-1269-1 | HealthFirst | 17 September 2018 |
| 1 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 51662-1269-2 | HealthFirst | 22 January 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 12 August 1981 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Verapamil
Clinical summary
Verapamil is a calcium channel blocker indicated for the treatment of supraventricular tachyarrhythmias, including rapid conversion to sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (Wolff-Parkinson-White [WPW] and Lown-Ganong-Levine [LGL] syndromes). MedsAcross supplies Verapamil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about VerapamilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Verapamil Hydrochloride prescribing information (Exela Pharma Sciences) · U.S. National Library of Medicine, DailyMed
Need Verapamil 5 mg/2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.